Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
NC001 Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z)
Study Director
Start Date
10 / 2010
Trial Phase
Trial Status
submitted for publication
Current Enrollment
Target Enrollment
85
Overview
Compound Associations
Pretomanid (PA-824) in combination with bedaquiline, moxifloxacin, pyrazinamide, and linezolid